INSUBCONTINENT EXCLUSIVE:
CHICAGO (Reuters) - A spike in suicide rates in the United States has cast fresh light on the need for more effective treatments for major
depression, with researchers saying it is a tricky development area that has largely been abandoned by big pharmaceutical companies.
